GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Imugene Ltd (ASX:IMU) » Definitions » Net Policyholder Benefits/Claims

Imugene (ASX:IMU) Net Policyholder Benefits/Claims


View and export this data going back to 1993. Start your Free Trial

What is Imugene Net Policyholder Benefits/Claims?

Net Policyholder Benefits/Claims only applies to insurance companies.


Imugene (ASX:IMU) Business Description

Industry
Traded in Other Exchanges
Address
4-6 Bligh Street, Suite 12.01, Level 12, Sydney, NSW, AUS, 2000
Imugene Ltd specializes in a clinical-stage immuno-oncology company. Its product includes HER-Vaxx,PD1-Vaxx, CF33 and CF33 CD19. HER-Vaxx is a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu. The company is also developing B-cell peptide cancer vaccines and therapeutics. Its only operating segment being the Research and Development of oncolytic immunotherapies.